Literature DB >> 22349907

Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem.

Daniel Grammel1, Monika Warmuth-Metz, André O von Bueren, Marcel Kool, Torsten Pietsch, Hans A Kretzschmar, David H Rowitch, Stefan Rutkowski, Stefan M Pfister, Ulrich Schüller.   

Abstract

Medulloblastoma is a malignant brain tumor of childhood that comprises at least four molecularly distinct subgroups. We have previously described that cerebellar granule neuron precursors may give rise to the subgroup with a molecular fingerprint of Sonic hedgehog (Shh) signaling. Other recent data indicate that precursor cells within the dorsal brain stem may serve as cellular origins for Wnt-associated medulloblastomas. To see whether Shh-associated medulloblastomas are also able to develop in the dorsal brainstem, we analyzed two lines of transgenic mice with constitutive Shh signaling in hGFAP- and Math1-positive brainstem precursor populations, respectively. Our results show that in both of these lines, medulloblastomas arise from granule neuron precursors of the cochlear nuclei, a derivative of the auditory lower rhombic lip. This region is distinct from derivatives of precerebellar lower rhombic lip where medulloblastomas arise in mice with constitutive-active Wnt signaling. With respect to their histology and the expression of appropriate markers, Shh tumors from the murine cochlear nuclei perfectly resemble human Shh-associated medulloblastomas. Moreover, we find that in a series of 63 human desmoplastic medulloblastomas, 21 (33%) have a very close contact to the cochlear nuclei on MR imaging. In conclusion, we demonstrate that precursors of the murine rhombic lip, which either develop into cerebellar or into cochlear granule neurons, may give rise to Shh-associated medulloblastoma, and this has important implications for the cellular origin of human medulloblastomas.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22349907     DOI: 10.1007/s00401-012-0961-0

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  33 in total

Review 1.  Genetic and molecular alterations across medulloblastoma subgroups.

Authors:  Patryk Skowron; Vijay Ramaswamy; Michael D Taylor
Journal:  J Mol Med (Berl)       Date:  2015-09-09       Impact factor: 4.599

Review 2.  Developmental origins and oncogenic pathways in malignant brain tumors.

Authors:  Q Richard Lu; Lily Qian; Xianyao Zhou
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2019-04-03       Impact factor: 5.814

3.  Distinctive localization and MRI features correlate of molecular subgroups in adult medulloblastoma.

Authors:  Fu Zhao; Chunde Li; Qiangyi Zhou; Peiran Qu; Bo Wang; Xin Wang; Shun Zhang; Xingchao Wang; Chi Zhao; Jing Zhang; Lin Luo; Lin Ai; Lei Xu; Pinan Liu
Journal:  J Neurooncol       Date:  2017-08-14       Impact factor: 4.130

Review 4.  Medulloblastoma-translating discoveries from the bench to the bedside.

Authors:  Amar J Gajjar; Giles W Robinson
Journal:  Nat Rev Clin Oncol       Date:  2014-10-28       Impact factor: 66.675

5.  Hedgehog signaling pathway and ovarian cancer.

Authors:  Qi Chen; Guolan Gao; Shiwen Luo
Journal:  Chin J Cancer Res       Date:  2013-06       Impact factor: 5.087

6.  Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.

Authors:  Marcel Kool; David T W Jones; Natalie Jäger; Paul A Northcott; Trevor J Pugh; Volker Hovestadt; Rosario M Piro; L Adriana Esparza; Shirley L Markant; Marc Remke; Till Milde; Franck Bourdeaut; Marina Ryzhova; Dominik Sturm; Elke Pfaff; Sebastian Stark; Sonja Hutter; Huriye Seker-Cin; Pascal Johann; Sebastian Bender; Christin Schmidt; Tobias Rausch; David Shih; Jüri Reimand; Laura Sieber; Andrea Wittmann; Linda Linke; Hendrik Witt; Ursula D Weber; Marc Zapatka; Rainer König; Rameen Beroukhim; Guillaume Bergthold; Peter van Sluis; Richard Volckmann; Jan Koster; Rogier Versteeg; Sabine Schmidt; Stephan Wolf; Chris Lawerenz; Cynthia C Bartholomae; Christof von Kalle; Andreas Unterberg; Christel Herold-Mende; Silvia Hofer; Andreas E Kulozik; Andreas von Deimling; Wolfram Scheurlen; Jörg Felsberg; Guido Reifenberger; Martin Hasselblatt; John R Crawford; Gerald A Grant; Nada Jabado; Arie Perry; Cynthia Cowdrey; Sydney Croul; Gelareh Zadeh; Jan O Korbel; Francois Doz; Olivier Delattre; Gary D Bader; Martin G McCabe; V Peter Collins; Mark W Kieran; Yoon-Jae Cho; Scott L Pomeroy; Olaf Witt; Benedikt Brors; Michael D Taylor; Ulrich Schüller; Andrey Korshunov; Roland Eils; Robert J Wechsler-Reya; Peter Lichter; Stefan M Pfister
Journal:  Cancer Cell       Date:  2014-03-17       Impact factor: 31.743

7.  A mouse model for embryonal tumors with multilayered rosettes uncovers the therapeutic potential of Sonic-hedgehog inhibitors.

Authors:  Julia E Neumann; Annika K Wefers; Sander Lambo; Edoardo Bianchi; Marie Bockstaller; Mario M Dorostkar; Valerie Meister; Pia Schindler; Andrey Korshunov; Katja von Hoff; Johannes Nowak; Monika Warmuth-Metz; Marlon R Schneider; Ingrid Renner-Müller; Daniel J Merk; Mehdi Shakarami; Tanvi Sharma; Lukas Chavez; Rainer Glass; Jennifer A Chan; M Mark Taketo; Philipp Neumann; Marcel Kool; Ulrich Schüller
Journal:  Nat Med       Date:  2017-09-11       Impact factor: 53.440

8.  Heterozygous mutation of sonic hedgehog receptor (Ptch1) drives cerebellar overgrowth and sex-specifically alters hippocampal and cortical layer structure, activity, and social behavior in female mice.

Authors:  Thomas W Jackson; Gabriel A Bendfeldt; Kelby A Beam; Kylie D Rock; Scott M Belcher
Journal:  Neurotoxicol Teratol       Date:  2020-02-27       Impact factor: 3.763

Review 9.  The role of stem cells and progenitors in the genesis of medulloblastoma.

Authors:  Jun Wang; Robert J Wechsler-Reya
Journal:  Exp Neurol       Date:  2012-11-22       Impact factor: 5.330

Review 10.  Medulloblastomics: the end of the beginning.

Authors:  Paul A Northcott; David T W Jones; Marcel Kool; Giles W Robinson; Richard J Gilbertson; Yoon-Jae Cho; Scott L Pomeroy; Andrey Korshunov; Peter Lichter; Michael D Taylor; Stefan M Pfister
Journal:  Nat Rev Cancer       Date:  2012-12       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.